TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis

Marlene Andersen, Michael Kruse Meyer, Ivan Nagaev, Olga Nagaeva, Jarl E. S. Wikberg, Lucia Mincheva-Nilsson, Grethe Neumann Andersen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number1516
JournalArthritis & Rheumatology
Volume66
Issue number10 (Supplement)
Pages (from-to)S666-7
ISSN1537-2960
Publication statusPublished - 2014
Event2014 ACR/ARHP Annual Meeting - Boston, United States
Duration: 14 Nov 201419 Nov 2014

Conference

Conference2014 ACR/ARHP Annual Meeting
CountryUnited States
CityBoston
Period14/11/201419/11/2014

Cite this

Andersen, M., Meyer, M. K., Nagaev, I., Nagaeva, O., Wikberg, J. E. S., Mincheva-Nilsson, L., & Andersen, G. N. (2014). TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis. Arthritis & Rheumatology, 66(10 (Supplement)), S666-7. [1516].
Andersen, Marlene ; Meyer, Michael Kruse ; Nagaev, Ivan ; Nagaeva, Olga ; Wikberg, Jarl E. S. ; Mincheva-Nilsson, Lucia ; Andersen, Grethe Neumann. / TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis. In: Arthritis & Rheumatology. 2014 ; Vol. 66, No. 10 (Supplement). pp. S666-7.
@article{c1ab4f6a5cef4437bd5e8e166d2a82f1,
title = "TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis",
author = "Marlene Andersen and Meyer, {Michael Kruse} and Ivan Nagaev and Olga Nagaeva and Wikberg, {Jarl E. S.} and Lucia Mincheva-Nilsson and Andersen, {Grethe Neumann}",
year = "2014",
language = "English",
volume = "66",
pages = "S666--7",
journal = "Arthritis & Rheumatology",
issn = "2326-5205",
publisher = "Wiley",
number = "10 (Supplement)",

}

Andersen, M, Meyer, MK, Nagaev, I, Nagaeva, O, Wikberg, JES, Mincheva-Nilsson, L & Andersen, GN 2014, 'TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis', Arthritis & Rheumatology, vol. 66, no. 10 (Supplement), 1516, pp. S666-7.

TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis. / Andersen, Marlene; Meyer, Michael Kruse; Nagaev, Ivan; Nagaeva, Olga; Wikberg, Jarl E. S.; Mincheva-Nilsson, Lucia; Andersen, Grethe Neumann.

In: Arthritis & Rheumatology, Vol. 66, No. 10 (Supplement), 1516, 2014, p. S666-7.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

TY - ABST

T1 - TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis

AU - Andersen, Marlene

AU - Meyer, Michael Kruse

AU - Nagaev, Ivan

AU - Nagaeva, Olga

AU - Wikberg, Jarl E. S.

AU - Mincheva-Nilsson, Lucia

AU - Andersen, Grethe Neumann

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

VL - 66

SP - S666-7

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 2326-5205

IS - 10 (Supplement)

M1 - 1516

ER -

Andersen M, Meyer MK, Nagaev I, Nagaeva O, Wikberg JES, Mincheva-Nilsson L et al. TNF-Alpha Inhibitors Normalizes Melanocortin Receptor Subtype 2, 3 and 4 Expression in CD8, CD14 and CD19 Leukocyte Subsets in Rheumatoid Arthritis. Arthritis & Rheumatology. 2014;66(10 (Supplement)):S666-7. 1516.